Inventor · disambiguated record
Eric Reed Lazear
Also filed as: LAZEAR ERIC REED
4 granted patents·4 pending applications·11 citations·filing 2015–2023
70Inventor score
Top patents by PatentIndex Score
8 records- 0191US11053293B2Compositions and methods for targeted cytokine deliveryUNIV WASHINGTON·Filed 2017·Granted Jul 6, 2021·8 cites·11 claims
- 0283US11713342B2Compositions and methods for targeted cytokine deliveryWASHINGTON UNIVERSITY ST LOUIS·Filed 2020·Granted Aug 1, 2023·1 cites·7 claims
- 0383US10793613B2Compositions and methods for targeted cytokine deliveryUNIV WASHINGTON·Filed 2015·Granted Oct 6, 2020·2 cites·9 claims
- 0477US2024376169A1Compositions and methods for targeted cytokine deliveryWASHINGTON UNIVERSITY ST LOUIS·Filed 2023·Application pending·0 cites
- 0575US2024092854A1Compositions and methods for targeted cytokine deliveryWASHINGTON UNIVERSITY ST LOUIS·Filed 2023·Application pending·0 cites
- 0670US11897929B2Compositions and methods for targeted cytokine deliveryWASHINGTON UNIVERSITY ST LOUIS·Filed 2021·Granted Feb 13, 2024·0 cites·5 claims
- 0749US2023002450A1Bispecific Fusion Protein Using Orthopoxvirus Major Histocompatibility Complex (MHC) Class I-Like Protein (OMCP) and Tumor-Specific Binding PartnerCOURIER THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0841US2022323541A1Orthopoxvirus major histocompatibility complex (mhc) class-i like protein (omcp) for treatment of autoimmune diseaseCOURIER THERAPEUTICS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Eric Reed Lazear files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →